|
Cushman, M; Casimiro-Garcia, A; Hejchman, E et al. (1998) New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors. J Med Chem 41:2076-89
|
|
Keyes, R F; Golebiewski, W M; Cushman, M (1996) Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements. J Med Chem 39:508-14
|
|
Cushman, M; Golebiewski, W M; Graham, L et al. (1996) Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors. J Med Chem 39:3217-27
|
|
Golebiewski, W M; Keyes, R F; Cushman, M (1996) Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues. Bioorg Med Chem 4:1637-48
|
|
Cushman, M; Golebiewski, W M; Pommier, Y et al. (1995) Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. J Med Chem 38:443-52
|
|
Cushman, M; Golebiewski, W M; McMahon, J B et al. (1994) Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. J Med Chem 37:3040-50
|
|
Cushman, M; Sherman, P (1992) Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem Biophys Res Commun 185:85-90
|
